69 related articles for article (PubMed ID: 19367645)
21. Purification and biochemical characterization of recombinant rat liver phenylalanine hydroxylase produced in Escherichia coli.
Citron BA; Davis MD; Kaufman S
Protein Expr Purif; 1992 Apr; 3(2):93-100. PubMed ID: 1422220
[TBL] [Abstract][Full Text] [Related]
22. Activation of phenylalanine hydroxylase: effect of substitutions at Arg68 and Cys237.
Thórólfsson M; Teigen K; Martínez A
Biochemistry; 2003 Apr; 42(12):3419-28. PubMed ID: 12653545
[TBL] [Abstract][Full Text] [Related]
23. Electrostatic activation of rat phenylalanine hydroxylase.
Citron BA; Davis MD; Kaufman S
Biochem Biophys Res Commun; 1994 Jan; 198(1):174-80. PubMed ID: 7904815
[TBL] [Abstract][Full Text] [Related]
24. The structural basis of the recognition of phenylalanine and pterin cofactors by phenylalanine hydroxylase: implications for the catalytic mechanism.
Teigen K; Frøystein NA; Martínez A
J Mol Biol; 1999 Dec; 294(3):807-23. PubMed ID: 10610798
[TBL] [Abstract][Full Text] [Related]
25. [Oligomerization of phenylalanine hydroxylase during its activation with phenylalanine].
Chestkov VV; Kovalev LI; Shishkin SS; Annenkov GA
Vopr Med Khim; 1985; 31(4):60-5. PubMed ID: 4049788
[TBL] [Abstract][Full Text] [Related]
26. L-cysteine desulfidase: an [4Fe-4S] enzyme isolated from Methanocaldococcus jannaschii that catalyzes the breakdown of L-cysteine into pyruvate, ammonia, and sulfide.
Tchong SI; Xu H; White RH
Biochemistry; 2005 Feb; 44(5):1659-70. PubMed ID: 15683250
[TBL] [Abstract][Full Text] [Related]
27. Prochiral sulfoxidation as a probe for multiple forms of the microsomal flavin-containing monooxygenase: studies with rabbit FMO1, FMO2, FMO3, and FMO5 expressed in Escherichia coli.
Rettie AE; Lawton MP; Sadeque AJ; Meier GP; Philpot RM
Arch Biochem Biophys; 1994 Jun; 311(2):369-77. PubMed ID: 8203899
[TBL] [Abstract][Full Text] [Related]
28. L-[2,5-H2]phenylalanine, an alternate substrate for rat liver phenylalanine hydroxylase.
Miller RJ; Benkovic SJ
Biochemistry; 1988 May; 27(10):3658-63. PubMed ID: 3408719
[TBL] [Abstract][Full Text] [Related]
29. Recombinant human phenylalanine hydroxylase is a substrate for the ubiquitin-conjugating enzyme system.
Døskeland AP; Flatmark T
Biochem J; 1996 Nov; 319 ( Pt 3)(Pt 3):941-5. PubMed ID: 8921003
[TBL] [Abstract][Full Text] [Related]
30. Cooperative homotropic interaction of L-noradrenaline with the catalytic site of phenylalanine 4-monooxygenase.
Martínez A; Haavik J; Flatmark T
Eur J Biochem; 1990 Oct; 193(1):211-9. PubMed ID: 2226440
[TBL] [Abstract][Full Text] [Related]
31. Insights into the mechanisms of ifosfamide encephalopathy: drug metabolites have agonistic effects on alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate receptors and induce cellular acidification in mouse cortical neurons.
Chatton JY; Idle JR; Vågbø CB; Magistretti PJ
J Pharmacol Exp Ther; 2001 Dec; 299(3):1161-8. PubMed ID: 11714908
[TBL] [Abstract][Full Text] [Related]
32. Use of surface plasmon resonance for real-time measurements of the global conformational transition in human phenylalanine hydroxylase in response to substrate binding and catalytic activation.
Flatmark T; Stokka AJ; Berge SV
Anal Biochem; 2001 Jul; 294(2):95-101. PubMed ID: 11444803
[TBL] [Abstract][Full Text] [Related]
33. Contrasting effects of N5-substituted tetrahydrobiopterin derivatives on phenylalanine hydroxylase, dihydropteridine reductase and nitric oxide synthase.
Werner ER; Habisch HJ; Gorren AC; Schmidt K; Canevari L; Werner-Felmayer G; Mayer B
Biochem J; 2000 Jun; 348 Pt 3(Pt 3):579-83. PubMed ID: 10839989
[TBL] [Abstract][Full Text] [Related]
34. Phenylalanine hydroxylase from Chromobacterium violaceum is a copper-containing monooxygenase. Kinetics of the reductive activation of the enzyme.
Pember SO; Villafranca JJ; Benkovic SJ
Biochemistry; 1986 Oct; 25(21):6611-9. PubMed ID: 3024714
[TBL] [Abstract][Full Text] [Related]
35. The V388M mutation results in a kinetic variant form of phenylalanine hydroxylase.
Leandro P; Rivera I; Lechner MC; de Almeida IT; Konecki D
Mol Genet Metab; 2000 Mar; 69(3):204-12. PubMed ID: 10767175
[TBL] [Abstract][Full Text] [Related]
36. Effect of genetic variants of the human flavin-containing monooxygenase 3 on N- and S-oxygenation activities.
Shimizu M; Yano H; Nagashima S; Murayama N; Zhang J; Cashman JR; Yamazaki H
Drug Metab Dispos; 2007 Mar; 35(3):328-30. PubMed ID: 17142560
[TBL] [Abstract][Full Text] [Related]
37. Bacterial plate assays and electrochemical methods: an efficient tandem for evaluating the ability of catechol-thioether metabolites of MDMA ("ecstasy") to induce toxic effects through redox-cycling.
Felim A; Urios A; Neudörffer A; Herrera G; Blanco M; Largeron M
Chem Res Toxicol; 2007 Apr; 20(4):685-93. PubMed ID: 17355154
[TBL] [Abstract][Full Text] [Related]
38. The activity of wild-type and mutant phenylalanine hydroxylase and its regulation by phenylalanine and tetrahydrobiopterin at physiological and pathological concentrations: an isothermal titration calorimetry study.
Pey AL; Martinez A
Mol Genet Metab; 2005 Dec; 86 Suppl 1():S43-53. PubMed ID: 15936235
[TBL] [Abstract][Full Text] [Related]
39. Thermodynamic characterization of the binding of tetrahydropterins to phenylalanine hydroxylase.
Pey AL; Thórólfsson M; Teigen K; Ugarte M; Martínez A
J Am Chem Soc; 2004 Oct; 126(42):13670-8. PubMed ID: 15493924
[TBL] [Abstract][Full Text] [Related]
40. Phenylalanine 4-monooxygenase: the "sulfoxidation polymorphism".
Mitchell SC; Steventon GB
Xenobiotica; 2020 Jan; 50(1):51-63. PubMed ID: 31233370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
